+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Arthritis Market - Global Forecast 2026-2032- Product Image
Canine Arthritis Market - Global Forecast 2026-2032- Product Image
New

Canine Arthritis Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6010632
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The canine arthritis market is rapidly evolving, challenging industry leaders to align innovative clinical approaches, commercial strategies, and supply chain resilience as new therapies, channels, and care models reshape the competitive landscape.

Market Snapshot: Canine Arthritis Market

The Canine Arthritis Market grew from USD 2.08 billion in 2025 to USD 2.27 billion in 2026. It is projected to expand at a CAGR of 8.39%, reaching USD 3.67 billion by 2032. Growth is driven by rising pet ownership, increased demand for advanced therapies, broader awareness of canine osteoarthritis, and evolving pet care expenditures among owners and veterinary practices.

Scope & Segmentation

  • Treatment Types: Pharmacological (NSAIDs, disease-modifying agents, monoclonal antibodies), biologics, complementary therapies (nutraceuticals, supplements), and nonpharmacological modalities such as physiotherapy and diagnostics.
  • Drug Classes: Nonsteroidal anti-inflammatory drugs, disease-modifying osteoarthritic agents, monoclonal antibodies, chondroprotective agents.
  • Routes of Administration: Subcutaneous injectables, oral tablets and capsules, topical gels.
  • Distribution Channels: Online pharmacies, veterinarian-focused e-commerce, pet specialty retail, veterinary hospital pharmacies, general retail pharmacies.
  • End Users: Veterinary hospitals, specialty clinics, general practice veterinary clinics, rehabilitation centers, pet owners accessing prescription and nonprescription options.
  • Regional Coverage: Americas, Europe Middle East & Africa (EMEA), Asia-Pacific; each region characterized by unique regulatory conditions, clinical protocols, and distribution ecosystems.
  • Key Technologies: Targeted biologics, telemedicine and digital consultation tools, structured rehabilitation protocols, digital supply chain tracking.
  • Top Players: Dechra, Elanco, Zoetis, and other manufacturers investing in diversified portfolios and clinician partnerships.

Key Takeaways for Senior Executives

  • The canine arthritis market demands integration of clinical evidence with streamlined delivery models and multifaceted product strategies for both acute and chronic conditions.
  • Emergence of new therapies—such as monoclonal antibodies and advanced disease-modifying solutions—requires manufacturers to enhance clinician education programs and support real-world adoption.
  • Supply chain resilience and regional sourcing are crucial as companies confront evolving trade policies—positioning supplier collaboration and scenario planning as mitigation strategies.
  • Channel dynamics are shifting, with online pharmacies and digitally-enabled veterinary services increasing their role in both owner-initiated and clinic-driven purchasing patterns.
  • Regional differences in practice standards, regulatory frameworks, and reimbursement models force manufacturers to tailor commercialization and distribution plans for each major global market.
  • Partnership-driven engagement, particularly with specialty clinics and rehabilitation centers, strongly supports differentiation and builds long-term adoption among clinicians and owners alike.

Tariff Impact and Strategic Supply Chain Responses

United States tariff policy changes have introduced heightened cost pressures and volatility for imported pharmaceutical ingredients and related products within the canine arthritis market. To manage these impacts, leading companies diversify suppliers, consider nearshoring of manufacturing steps, and strengthen logistics visibility. Cost increases drive a shift toward domestically produced alternatives, dose optimization, and deeper alignment with large veterinary networks to secure continuity and stable pricing. For emerging suppliers, these dynamics mean recalibrating entry and partnership strategies to remain competitive amid rising operational costs.

Methodology & Data Sources

This report uses a robust mixed-methods approach, combining primary research (expert interviews with veterinarians, supply chain executives, and rehabilitation specialists), secondary clinical literature analysis, and comparative case studies. Scenario modeling and stakeholder validation workshops ensure actionable insights that align with actual clinical and market practices.

Why This Report Matters

  • Enables executive teams to position portfolios and investments in line with treatment innovation and commercial channel evolution across key regions.
  • Provides validated recommendations for navigating trade policy risks and sustaining supply continuity, crucial for sustained access to advanced therapies.
  • Delivers actionable segmentation and regional trend insights to support strategic planning and resource allocation.

Conclusion

The canine arthritis market is experiencing transformational shifts in clinical management, distribution, and supply chain strategies. Stakeholders who prioritize coordinated evidence generation and supply resilience—while adapting commercial models—will be better positioned to secure sustainable growth and improved outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Canine Arthritis Market, by Treatment Type
8.1. Complementary Therapies
8.1.1. Nutraceuticals
8.1.2. Supplements
8.1.2.1. Chondroitin
8.1.2.2. Glucosamine
8.1.2.3. Omega Fatty Acids
8.2. Non Pharmacological Therapies
8.2.1. Acupuncture
8.2.2. Laser Therapy
8.2.3. Physical Therapy
8.2.3.1. Hydrotherapy
8.2.3.2. Physiotherapy
8.3. Pharmacological Therapies
8.3.1. Disease Modifying Agents
8.3.1.1. Hyaluronic Acid
8.3.1.2. Polysulfated Glycosaminoglycan
8.3.2. Monoclonal Antibodies
8.3.3. Non Steroidal Anti Inflammatory Drugs
8.3.3.1. Carprofen
8.3.3.2. Deracoxib
8.3.3.3. Meloxicam
9. Canine Arthritis Market, by Drug Class
9.1. Disease Modifying Osteoarthritic Agents
9.1.1. Hyaluronic Acid
9.1.2. Polysulfated Glycosaminoglycan
9.2. Monoclonal Antibodies
9.3. Non Steroidal Anti Inflammatory Drugs
9.3.1. Carprofen
9.3.2. Deracoxib
9.3.3. Meloxicam
10. Canine Arthritis Market, by Route Of Administration
10.1. Injectable
10.2. Oral
10.3. Topical
11. Canine Arthritis Market, by End User
11.1. Veterinary Clinics
11.2. Veterinary Hospitals
12. Canine Arthritis Market, by Distribution Channel
12.1. Online
12.2. Offline
13. Canine Arthritis Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Canine Arthritis Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Canine Arthritis Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Canine Arthritis Market
17. China Canine Arthritis Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. American Regent, Inc.
18.6. Aratana Therapeutics, Inc.
18.7. Bayer Animal Health GmbH
18.8. Bimeda Holdings PLC
18.9. Boehringer Ingelheim Vetmedica GmbH
18.10. Ceva Santé Animale S.A.
18.11. Dechra Pharmaceuticals PLC
18.12. Elanco Animal Health Incorporated
18.13. Heska Corporation
18.14. Indian Immunologicals Limited
18.15. Innovet Pet Products, Inc.
18.16. Kemin Industries, Inc.
18.17. Merck Animal Health
18.18. Neogen Corporation
18.19. Norbrook Laboratories Limited
18.20. Nutramax Laboratories, Inc.
18.21. Ourofino Saúde Animal Participações S.A.
18.22. Phibro Animal Health Corporation
18.23. Vetoquinol S.A.
18.24. VetPlus Ltd.
18.25. VetriScience Laboratories
18.26. Virbac S.A.
18.27. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CANINE ARTHRITIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CANINE ARTHRITIS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CANINE ARTHRITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CANINE ARTHRITIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NUTRACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NUTRACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CHONDROITIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CHONDROITIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CHONDROITIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GLUCOSAMINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GLUCOSAMINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GLUCOSAMINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OMEGA FATTY ACIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OMEGA FATTY ACIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSIOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSIOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. EUROPE CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPE CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 188. EUROPE CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 189. EUROPE CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 190. EUROPE CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 191. EUROPE CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 192. EUROPE CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 193. EUROPE CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 196. EUROPE CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 198. EUROPE CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. EUROPE CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. AFRICA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 217. AFRICA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 218. AFRICA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 219. AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 220. AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 221. AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 222. AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 223. AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 224. AFRICA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 225. AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 226. AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 228. AFRICA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 246. ASEAN CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. ASEAN CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 248. ASEAN CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 249. ASEAN CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 250. ASEAN CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 251. ASEAN CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 252. ASEAN CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 253. ASEAN CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 254. ASEAN CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 255. ASEAN CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 256. ASEAN CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 257. ASEAN CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 258. ASEAN CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 259. ASEAN CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. ASEAN CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. GCC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. GCC CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 263. GCC CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 264. GCC CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 265. GCC CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 266. GCC CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 267. GCC CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 268. GCC CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 269. GCC CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 270. GCC CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 271. GCC CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 272. GCC CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 273. GCC CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 274. GCC CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. GCC CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 291. BRICS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 292. BRICS CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 293. BRICS CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 294. BRICS CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 295. BRICS CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 296. BRICS CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 297. BRICS CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 298. BRICS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 299. BRICS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 300. BRICS CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 301. BRICS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 302. BRICS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 303. BRICS CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 304. BRICS CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 305. BRICS CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 306. G7 CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 307. G7 CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 308. G7 CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2032 (USD MILLION)
TABLE 309. G7 CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 310. G7 CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 311. G7 CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 312. G7 CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 313. G7 CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2032 (USD MILLION)
TABLE 314. G7 CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 315. G7 CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 316. G7 CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2032 (USD MILLION)
TABLE 317. G7 CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2032 (USD MILLION)
TABLE 318. G7 CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 319. G7 CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 320. G7 CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLIO

Companies Mentioned

The key companies profiled in this Canine Arthritis market report include:
  • American Regent, Inc.
  • Aratana Therapeutics, Inc.
  • Bayer Animal Health GmbH
  • Bimeda Holdings PLC
  • Boehringer Ingelheim Vetmedica GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Indian Immunologicals Limited
  • Innovet Pet Products, Inc.
  • Kemin Industries, Inc.
  • Merck Animal Health
  • Neogen Corporation
  • Norbrook Laboratories Limited
  • Nutramax Laboratories, Inc.
  • Ourofino Saúde Animal Participações S.A.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • VetPlus Ltd.
  • VetriScience Laboratories
  • Virbac S.A.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.27 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.67 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Canine Arthritis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Canine Arthritis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Canine Arthritis Treatment Market Report and Forecast 2025-2034 - Product Image

Canine Arthritis Treatment Market Report and Forecast 2025-2034

  • Report
  • 153 Pages
  • Global
From
Canine Arthritis Treatment - Global Strategic Business Report - Product Image

Canine Arthritis Treatment - Global Strategic Business Report

  • Report
  • 214 Pages
  • Global
From
Canine Arthritis Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Canine Arthritis Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Canine Arthritis Treatment Market 2025-2029 - Product Image

Canine Arthritis Treatment Market 2025-2029

  • Report
  • 215 Pages
  • Global
From

About the Canine Arthritis Drugs Market

The Canine Arthritis Drugs market is a segment of the Animal Pharmaceuticals industry that focuses on providing medications to treat arthritis in dogs. These drugs are typically used to reduce inflammation and pain, as well as to slow the progression of the disease. Commonly used drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). In addition, supplements such as glucosamine and chondroitin are often used to help manage the symptoms of arthritis. The Canine Arthritis Drugs market is highly competitive, with a number of companies offering products to treat the condition. Some of the major players in the market include Zoetis, Elanco, Merck Animal Health, Bayer Animal Health, and Ceva Animal Health. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.